Drug
Gwp42003 P
Gwp42003 P: highest development phase Phase 2, developed by Jazz Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| GWP42003-P NCT04745026 | Phase 2 | Autism Spectrum Disorder |
Latest
No recent events.
Follow Gwp42003 P on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.